Reproduction permitted for personal use only. For reprints and reprint permission, contact

Scientific Protein Laboratories Acquired by New York firm

Waunakee, Wis. -- Scientific Protein Laboratories, a producer of active pharmaceutical ingredients (API), was acquired by New York-based Arsenal Capital Partners.
Arsenal, which targets specialty manufacturing, specialty chemicals and healthcare companies announced the acquisition, which is valued at $81 million, today.

SPL, based in Waunakee, Wis., is the world’s largest independent producer of heparin API, which is used to manufacture anticoagulants used in the prevention and treatment of thrombosis, embolism, acute coronary syndromes and surgical recoveries involving implants. SPL also manufactures pancreatin API, which is used to treat pancreatic deficiency of cystic fibrosis and a variety of digestive disorders.

“We look forward to working with the Arsenal Capital team to invest in our existing businesses as well as pursue new opportunities within the carbohydrate and natural protein product areas,” said David Strunce, president of SPL.


sandy zimmerman responded 7 years ago: #1

why does the article not mention that the heparin is made in china

-Add Your Comment


Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources. Comments are moderated and are not immediately posted. Your email address will not be posted.

WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact

WTN Media Presents